A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Stereotaxic Injection of a Viral Vector for Conditional Gene Manipulation in the Mouse Spinal Cord

31.1K views

⸱

DOI:

10.3791/50313

⸱

March 18th, 2013

 ,  ,  , 

In This Article

Summary

Viral vectors allow for targeted gene manipulation. We demonstrate a method for conditional gene expression or ablation in the mouse spinal cord, using stereotaxic injection of a viral vector into the dorsal horn, a prominent site of synaptic contact between primary somatosensory afferents and neurons of the central nervous system.

Abstract

Intraparenchymal injection of a viral vector enables conditional gene manipulation in distinct populations of neurons or particular regions of the central nervous system. We demonstrate a stereotaxic injection technique that allows targeted gene expression or silencing in the dorsal horn of the mouse spinal cord. The surgical procedure is brief. It requires laminectomy of a single vertebra, providing for quick recovery of the animal and unimpaired motility of the spine. Controlled injection of a small vector suspension volume at low speed and use of a microsyringe with beveled glass cannula minimize the tissue lesion. The local immune response to the vector depends on the intrinsic properties of the virus employed; in our experience, it is minor and short-lived when a recombinant adeno-associated virus is used. A reporter gene such as enhanced green fluorescent protein facilitates monitoring spatial distribution of the vector, and the efficacy and cellular specificity of the transfection.

Introduction

Advanced technologies of conditional gene manipulation in the mouse enable multifaceted approaches to the exploration of synaptic pathways and functional connections in the central nervous system. Transgenes may be regulated by small-molecule effectors such as doxycycline acting on a tetracycline-controlled transactivator, which can be designed to function as a repressor or an activator of gene transcription, or tamoxifen recognizing a mutated ligand-binding domain of the estrogen receptor 1. Irreversible transgene modification is commonly achieved by deoxyribonucleic acid (DNA) recombinases. Cre (causes recombination) and Flp (flippase recombination enzyme....

Access restricted. Please log in or start a trial to view this content.

Protocol

The surgical procedure described has been approved by the Institutional Animal Care and Use Committee (IACUC) of Columbia University.

1. Preparation of Equipment and Virus Particle Suspension

  1. Clean and disinfect the equipment, sterilize the surgical instruments and the V notch spikes that will be used to fix vertebra L1.
  2. Pull and bevel glass pipettes. We use pipettes that have a tip diameter of 40 μm and are beveled at an angle of 20°. Sterilize the glass pipettes.
  3. Set up the stereotaxic frame, mount the microsyringe injector onto the manipulator and connect the injector to the controller.
  4. At....

Access restricted. Please log in or start a trial to view this content.

Results

Successful transfection yields robust gene expression in neurons of the injected dorsal horn (Figure 1), sparing the dorsal horn of the contralateral side, the ventral horn and the dorsal root ganglia.

Fluorescent microscopy of neural tissue, showing red and green markers in merged images for analysis.
Figure 1. Transfection of dorsal horn neurons.

Access restricted. Please log in or start a trial to view this content.

Discussion

Stereotaxic vector injection allows targeting spinal cord neurons for applications such as neuronal network mapping based on transsynaptic virus spreading 6,7 or optogenetic dissection 8, axon guidance during regeneration from injury 9,10, or gene therapy for the prevention or treatment of neurodegeneration 11,12. Viral vectors have been used for gene manipulation in the spinal cord to study somatosensory, motor and autonomic pathways 9,10,13-15. The mouse is the mod.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare that they have no competing financial interests.

Acknowledgements

We thank Bakhos A. Tannous, Ph.D., Director of Vector Development and Production in the Neuroscience Center of Massachusetts General Hospital, Charlestown, Massachusetts, for providing us with the rAAV-eGfp vector, and John Whang for technical assistance. This work was supported by grant R01 NS050408 (to J.S.) from the National Institute of Neurological Disorders and Stroke.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Spinal base plateDavid Kopf Instruments912
Small animal stereotaxic instrumentDavid Kopf Instruments900
Mouse gas anesthesia head holderDavid Kopf Instruments923-B
Adjustable base mountsDavid Kopf Instruments982
V notch spikesDavid Kopf Instruments987
Small animal temperature control systemDavid Kopf InstrumentsTCAT-2LV
Adson forcepsFine Science Tools11006-12
Laminectomy forcepsFine Science Tools11223-20
UltraMicroPump (one) with SYS-Micro4 ControllerWorld Precision InstrumentsUMP3-1
Microsyringe, 65RNHamilton7633-01
RN compression fitting, 1 mmHamilton55750-01
Borosilicate glass capillariesWorld Precision Instruments1B100F-4
MicrogrinderNarishigeEG-44

References

  1. Lewandoski, M. Conditional control of gene expression in the mouse. Nature Reviews Genetics. 2, 743-755 (2001).
  2. Couto, L. B., High, K. A. Viral vector-mediated RNA interference. Curr. Opin. Pharmacol. 10, 534-542 (2010).
  3. Luo, L., Callaway, E. M., Svoboda, K.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Laminectomy ProcedureGlass PipetteMicro SyringeEnhanced Green Fluorescent ProteinDorsal HornSurgical Technique